Perceptual responses in patients with inflammatory and functional Bowel disease

Gut

Volumn 47, Issue 4, 2000, Pages 497-505

  Chang, L ^a,b   Munakata, J ^a   Mayer, E A ^a   Schmulson, M J ^a   Johnson, T D ^c   Bernstein, C N ^a,d   Saba, L ^a   Naliboff, B ^a   Anton, P A ^a   Matin, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Abdominal pain; Irritable bowel syndrome; Ulcerative colitis

Indexed keywords

ABDOMINAL DISCOMFORT; ADULT; AGED; ANTINOCICEPTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HYPERALGESIA; INTESTINE DISTENSION; IRRITABLE COLON; MALE; MUCOSA INFLAMMATION; PATIENT; PERCEPTION; PRIORITY JOURNAL; SCORING SYSTEM; ULCERATIVE COLITIS;

ADULT; AGED; BALLOON DILATATION; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONIC DISEASES, FUNCTIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; PERCEPTION; SEVERITY OF ILLNESS INDEX;

EID: 0033804706     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.4.497     Document Type: Article

References (41)

1. 1 Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996;347:150-3.
2. 2 Chaudhary NA, Truelove SC. The irritable colon syndrome. Q J Med 1962;31:307-22.
3. 3 Gwee KA. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
4. 4 Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-93.
5. 5 Collins S, Mayer EA, Raybould HE, ed. Basic and clinical aspects of chronic abdominal pain. Amsterdam: Elsevier, 1993:62-70.
6. 6 Rao SSC, Read NW, Davison PA, et al. Anorectal sensitivity and responses to rectal distension in patients with ulcerative colitis. Gastroenterology 1987;93:1270-5.
7. 7 Loennig-Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol 1989;84:892-7.
8. 8 Farthing MJG, Lennard-Jones JE. Sensibility of the rectum to distension and the anorectal distension reflex in ulcerative colitis. Gut 1978;19:492-502.
9. 9 Bernstein CN, Niazi N, Robert M, et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996;66:151-61.
10. 10 Cook IJ, Van Eeden A, Collins SM. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987;93:727-33.
11. 11 Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997;112:55-63.
12. 12 Truelove SC, Witts LJ. Cortisone in ulcerative colitis. BMJ 1955;1:1041-8.
13. 13 Seo M, Okada M, Tsuneyoshi T, et al. Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification. Am J Gastroenterol 1995;90:1759-63.
14. 14 Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987;92: 1894-7.
15. 15 Thompson WG, Creed F, Drossman DA, et al. Functional bowel disease and functional abdominal pain. Gastroenterology Intl 1992;5:75-91.
16. 16 Manning AP, Thompson WD, Heaton KW, et al. Towards positive diagnosis in the irritable bowel syndrome. BMJ 1978;2:653-4.
17. 17 Gracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain 1978;5:5-18.
18. 18 Derogatis LR. SCL-90R. Administration, scoring and procedures manual - II. Towson, MD: NCS Assessments, 1983.
19. 19 Mertz H, Fass R, Hirsh T, et al. Amitryptiline for functional dyspepsia: effect on symptoms, gastric sensitivity and sleep. Gastroenterology 1995;108:A649.
20. 20 Prior A, Sorial E, Sun W-M, et al. Irritable bowel syndrome: differences between patients who show rectal sensitivity and those who do not. Eur J Gastroenterol Hepatol 1993;5:343-9.
21. 21 Lembo T, Munakata J, Mertz H, et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994;107:1686-96.
22. 22 Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
23. s23 Whitehead WE, Crowell MD, Shone D; et al. Sensitivity to rectal distension: validation of a measurement system. Gastroenterology 1993;104:A600.
24. 24 Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997;41:505-12.
25. 25 Hollander M, Wolfe DA. Nonparametric statistical methods. New York: John Wiley and Sons; 1973.
26. 26 Chang L, Mayer EA, Lembcke B, et al, eds. Systemic manifestations of IBD: Tlie pending challenge for subtle diagnosis and treatment. Amsterdam: Kluwer Academic Publishers, 1998:3-19.
27. 27 Denis P, Colin R, Galmiche JP, et al. Elastic properties of the rectal wall in normal adults and in patients with ulcerative colitis. Gastroenterology 1979;77:45-8.
28. 28 Ness TJ, Gebhart GF. Visceral pain: a review of experimental studies. Pain 1990;41:167-234.
29. 29 Coutinho SV, Meller ST, Gebhart GF. Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res 1996;736:7-15.
30. 30 Miampamba M, Chery-Croze S, Gorry F, et al. Inflammation of the colonic wall induced by formalin as a model of acute visceral pain. Pain 1994;57:327-34.
31. 31 Sengupta JN, Snider A, Su X, et al. Effects of kappa opioids in the inflamed rat colon. Pain 1999;79:175-85.
32. 32 Julia V, Mezzasalma T, Bueno L. Influence of bradykinin in gastrointestinal disorders and visceral pain induced by acute or chronic inflammation in rats. Dig Dis Sci 1995;40: 1913-21.
33. 33 Goldhill J, Pichat P, Roome N, et al. Effect of mizolastine on visceral sensory afferent sensitivity and inflammation during experimental colitis. Arzneimittelforschung 1998;48: 179-84.
34. 34 Morteau O, Julia V, Eeckhout C, et al. Influence of 5-HT, receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats. Fundam Clin Pharmacol 1994;8:553-62.
35. 35 Garrison DW, Chandler MJ, Foreman RD. Viscerosomatic convergence onto feline spinal neurons from esophagus, heart and somatic fields: effect of inflammation. Pain 1992; 49:373-82.
36. 36 Coutinho SV, Sengupta JN, Gebhart GF. Sensitized afferents from the inflamed colon are not involved in the maintenance of visceral hyperalgesia. Soc Neurosci Abstr 1997;23:1002.
37. 37 Fass R, Naliboff B, Higa L, et al. Differential effect of chronic esophageal acid exposure on mechano-and chemosensitivity in humans. Gastroenterology 1998;115: 1363-73.
38. 38 Mertz H, Fullerton S, Naliboff B, et al. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998;42:814-22.
39. 39 Loening-Baucke V, Metcalf AM, Shirazi S. Anorectal man ometry in active and quiescent ulcerative colitis. Am J Gastroenterol 1989;84:892-7.
40. 40 Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-90.
41. 41 Dixon NF. Preconscious processing. New York: John Wiley and Sons, 1987.